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BACKGROUND: Diagnosis of oral cancer is conventionally carried out using white light endoscopy and histopathology of biopsy samples.
However, oral tumours are mostly superficial and the lesion and its margins can be difficult to visualise under white light. We present
clinical data on fluorescence diagnostic imaging of oral lesions using hypericin, a plant-based photosensitiser.
METHODS: Fluorescence images of lesions and normal tissue were captured using an endoscope after hypericin administration. The
images were analysed to extract their colour parameters, which, along with the red-to-blue intensity ratios, were analysed and used
to discriminate between tissue types. The results were correlated with those from histopathology.
RESULTS: The red-to-blue intensity ratio increased from normal to hyperplastic to cancerous tissue and was a good parameter to
discriminate between these tissue types, with sensitivity and specificity levels of 90% and above.
CONCLUSION: Our results show that hypericin fluorescence imaging has the potential to be used for the clinical diagnosis of oral cancer.
Further study to enhance the clinical potential of this technique includes the development of a real-time image processing and analysis
system interfaced to the endoscope to enable same-day cancer diagnosis and demarcation of lesion margins in a clinical setting.
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Cancer of the oral cavity is one of the most common forms of
malignancy worldwide, with a majority of the cases occurring in
men, among whom the disease ranks as the eighth most com-
mon cancer (Parkin et al, 2005; Garcia et al, 2007). South Asia, in
particular, has relatively high incidence rates for both men and
women (Parkin et al, 2005). The 5-year survival is poor (about
50%) (Garcia et al, 2007). Early diagnosis is the key to a good
prognosis, hence it is important to develop a rapid and accurate
means for the detection of early oral cancer (Sciubba, 2001; Neville
and Day, 2002; D’Silva and Ward, 2007).
The predominant type (over 90%) of tumours in the oral cavity
is squamous cell carcinoma (SCC) (Neville and Day, 2002; D’Silva
and Ward, 2007). Diagnosis is conventionally achieved by white
light endoscopy, followed by histopathological examination
of biopsy tissue. However, there are a number of challenges
associated with the current diagnostic approach. First, oral lesions
tend to be flat and it might be difficult to distinguish benign from
malignant lesions using white light endoscopy. Second, it might be
difficult to determine the margins of lesions during procedures.
Moreover, genetically altered cells have been found to extend into
clinically and histologically ‘normal’ regions (van Houten et al,
2004; Poh et al, 2006). Third, histopathology requires time for
processing. Although biopsy procedures are generally safe, they
nevertheless carry a small risk of complications for patients. The
physician has to balance between reducing the number of biopsies
and a missed diagnosis through error in the choice of a sampling
site. Thus, although histopathology remains the gold standard for a
definitive diagnosis for oral cancer, the technique has its own
limitations, including small sample size and artefacts arising from
sampling and processing. Moreover, the interpretation of histology
results is dependent on the skill and experience of trained
specialists.
Fluorescence diagnostic imaging is a relatively new technique
that involves the use of a photosensitising drug to visualise
lesions through tissue fluorescence. Results from studies
using 5-aminolevulinic acid (5-ALA)-induced protophorphyrin
IX (PpIX) fluorescence have shown this technique to be superior to
white light endoscopy for the diagnosis of various types of cancer,
including those in the oral cavity (Betz et al, 2002; Zheng et al,
2002, 2004; Csanady et al, 2004). Hypericin is a plant-based
photosensitiser that accumulates selectively in abnormal cells,
including tumour cells (Olivo et al, 2006). We have previously
shown the potential for hypericin to be used as a fluorescence
contrast agent in ex vivo cytology and in in vivo fluorescence
imaging for the diagnosis of bladder cancer (Olivo et al, 2003;
Sim et al, 2005; Fu et al, 2007; Kah et al, 2008). We anticipate that
the use of hypericin with fluorescence endoscopy can improve the
sensitivity and specificity of oral cancer diagnosis compared with
white light alone, by providing an enhanced contrast between the
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slesion and surrounding normal tissue. In comparing hypericin
with 5-ALA-induced PpIX fluorescence cystoscopy for the detec-
tion of bladder cancer, D’Hallewin et al (2002) observed that
hypericin fluorescence provides improved specificity and is subject
to reduced photobleaching. Hypericin may thus offer similar
advantages over 5-ALA-induced PpIX fluorescence for endoscopic
imaging of oral cancer. In this study, we present hypericin
fluorescence diagnostic imaging as a technique that can comple-
ment standard white light endoscopy for the diagnosis of oral
cancer by (1) facilitating guided biopsies in the clinic, thereby
reducing the number of biopsies taken; (2) providing visualisation
of tumour margins during surgical procedures; and (3) providing a
means for same-day diagnosis in the clinic.
MATERIALS AND METHODS
Patients
Twenty-three patients (mean age: 59.3 years, s.d.: 13.5, range:
35–80 years, 74% males) with clinically suspicious or histologically
proven lesions in the oral cavity were recruited for the study after
obtaining informed consent. Within this patient pool, 13 lesions
were histopathologically characterised as hyperplasia, three as
cellular pleomorphic adenoma of the palate, four as dysplasia and
12 as SCC. Hyperplasia lesions typically ranged in sizes between
0.5 and 1cm, whereas SCC lesions were typically larger, ranging
from 1 to 4cm, with depths of invasion ranging from 3 to 20mm.
Ulceration was recorded in 25% of hyperplasia patients and in 55%
of SCC patients. Lymph node involvement was recorded in 25% of
patients with SCC. In addition to 32 lesions imaged, 31 normal oral
cavity sites in patients were also imaged, making a total of 63 sites
that were imaged. This study was approved by the Institutional
Review Board of the National Cancer Centre Singapore.
Hypericin preparation and administration
A stock solution was prepared by dissolving 1mg of hypericin
(Molecular Probes, Invitrogen Corporation, Carlsbad, CA, USA) in
125ml of ethanol. Hypericin stock (125ml) was added to 125ml of
1% serum albumin in phosphate-buffered saline, and stored at
 201C until use. Just before topical application, an 8mM hypericin
instillation solution was prepared by diluting the thawed prepara-
tion in saline, and then filtering. Hypericin solution (100ml) was
topically administered to each patient by oral rinsing over 30min.
Fluorescence endoscopy
The schematic diagram in Figure 1 shows the setup of a
fluorescence endoscopy system (Karl Storz Endoscope, Karl Storz
GmbH & Co., Tuttlingen, Germany) interfaced to a PC-based
image acquisition and analysis system for fluorescence diagnostic
imaging of human oral lesions in the clinic. The light source is a
100W xenon short arc lamp (Karl Storz D-light system, Karl Storz
GmbH & Co.) with filter options for white light (WL) and
fluorescence (FL) excitation. Fluorescence excitation light is
filtered by a band pass filter (380–440nm), whereas the emitted
fluorescence signal is filtered by a long pass observation filter
(cut-on wavelength 450nm). White light and fluorescence images
are captured by a 3-chip CCD camera (Karl Storz Tricam SL-PDD,
Karl Storz GmbH & Co.) and input to the PC-based image
acquisition and analysis system.
At 1.5 to 4h (mean 2.2h, s.d. 0.6h) after hypericin administra-
tion, fluorescence images of suspected lesions and normal regions
in the oral cavity of patients were acquired. Corresponding white
light images were acquired before the administration of hypericin
and/or after the completion of fluorescence imaging to avoid
photobleaching of hypericin because of white light illumination.
Image analysis
The fluorescence images acquired were analysed to extract the red,
green and blue (RGB) intensities, as well as the hue, saturation and
intensity (HSI) values of the images. The red-to-blue (R/B) and
red-to-green (R/G) intensity ratios were also calculated for each
image. Among the images acquired for each site, three sharpest
images were selected to obtain the mean values of R/B, R/G, H, S
and I. These mean image parameters were used to distinguish the
tissue type at three levels: (1) normal vs hyperplastic tissue; (2)
normal vs SCC tissue; and (3) hyperplastic vs SCC lesions.
Statistical analysis and calculations
To evaluate how well the image parameters can discriminate
between tissue types, one-way ANOVA analysis with Bonferroni’s
multiple comparison tests was carried out using GraphPad Prism
(GraphPad Software Inc., La Jolla, CA, USA) for a pairwise
comparison of the means. A P-value of less than 0.05 is considered
significant and is indicated by asterisks over the respective data pair
(*Po0.05; **Po0.01; ***Po0.001). The image parameters were also
analysed by the Receiver Operating Characteristics (ROC) curves
method using GraphPad Prism. ROC analysis provided the areas
under the curve, P-values and cutoff values for different sensitivity
and specificity levels. The sensitivity, specificity, positive predictive
value (PPV) and negative predictive value (NPV) of each test were
calculated using the following formulae:
Sensitivityð%Þ¼
TP
TP þ FN
 100
Specificityð%Þ¼
TN
TN þ FP
 100
PPV ð%Þ¼
TP
TP þ FP
 100
NPV ð%Þ¼
TN
TN þ FN
 100;
where TP is the number of true positives, FP the number of false
positives, TN the number of true negatives and FN the number of
false negatives.
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acquisition and analysis
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Figure 1 Schematic diagram of the setup showing a fluorescence
endoscopy system interfaced to a PC-based image acquisition and analysis
system for fluorescence diagnostic imaging of lesions in the human oral
cavity in a clinical setting. WL stands for white light; FL, fluorescence.
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sRESULTS
We have set up a relatively simple and portable system for
fluorescence diagnostic imaging. Figure 1 shows the schematic
diagram of the setup comprising a fluorescence endoscope
interfaced to a PC-based image acquisition and analysis system.
This setup enabled us to carry out white light and hypericin
fluorescence imaging of lesion and healthy sites in the human oral
cavity in a clinical setting. Red fluorescence was observed in
lesions, indicating a selective uptake of hypericin in lesions
compared with normal tissue.
A total of 63 lesion and normal sites from the tongue, buccal
mucosa, palate and gingiva were imaged. Figure 2 shows the white
light (A, B, C) and hypericin fluorescence (D, E, F) endoscopic
images of normal (A, D), hyperplastic (B, E) and SCC (C, F)
tongues. The fluorescence images show a progressive increase in
the red-to-blue intensity ratios from normal (R/B¼0.3) to
hyperplastic (R/B¼1.0) to SCC (R/B¼2.0) tissue.
The image parameters, hue, saturation and intensity, as well as
the ratiometric parameters, red-to-blue and red-to-green intensity
ratios, were extracted and analysed for their ability to distinguish
between normal and lesional oral tissue. Figure 3 shows the bar
charts of the mean values of the red-to-blue intensity ratios (A),
red-to-green intensity ratios (B), image hue (C) and image
intensity (D) in normal (n¼28), hyperplastic (n¼10) and SCC
(n¼12) oral cavity tissue. A pairwise comparison of the means
was carried out using one-way ANOVA with Bonferroni’s multiple
comparison tests. A P-value of less than 0.05 is considered
significant and is indicated by asterisks over the respective data
pair (*Po0.05; **Po0.01; ***Po0.001). The results show that the
red-to-blue intensity ratio and the image hue can best distinguish
between normal, hyperplastic and SCC oral tissue. The red-to-
green intensity ratio did reasonably well in distinguishing between
normal and SCC tissue, but was not good for distinguishing
between normal and hyperplastic tissue and between hyperplasia
and SCC. The image intensity was good for distinguishing between
normal and hyperplastic tissue and between normal and SCC
tissue, but not for distinguishing between hyperplasia and SCC.
The image saturation was a poor test parameter overall and the
results are not shown.
The above test parameters were also analysed using the ROC
curves method to check the quality of the test and obtain the cutoff
values for different levels of sensitivity vs specificity. The best
trade-off value offering the highest combined sensitivity and
specificity was chosen for the test parameter between each pair of
normal, hyperplastic and SCC data. Tables 1–3 show the ROC
results and the PPV and NPV for the test between (1) normal and
hyperplastic, (2) normal and SCC and (3) hyperplastic and SCC
oral tissue, respectively. For distinguishing between normal and
hyperplastic oral tissue, the red-to-blue (R/B) ratio and image hue
are good test parameters offering 96 and 100% specificity,
respectively, at a 100% sensitivity level. Similarly, for distinguish-
ing between normal and SCC tissue, the R/B ratio and hue are good
tests, both offering 100% specificity at a 100% sensitivity level. For
distinguishing between hyperplasia and SCC, the R/B ratio and hue
offer the best results at a specificity of 90 and 80%, respectively, at
a 92% sensitivity level.
Overall, the R/B ratio and hue are the best test parameters,
giving the best distinction between normal, hyperplastic and SCC
oral tissue. The red-to-green intensity ratio and image intensity
serve reasonably well to distinguish between normal and
hyperplastic and normal and SCC tissue, but distinguish poorly
between hyperplastic and SCC tissue. The image saturation value is
overall a poor discriminator of oral tissue type and the results are
not shown.
DISCUSSION
Fluorescence imaging of the human oral cavity using hypericin has
great potential as a complementary technique to standard white
light examination and histopathology of oral cavity lesions. Red
fluorescence was observed in lesions, indicating a selective uptake
of hypericin in lesions compared with normal tissue. Moreover,
hyperplastic and SCC lesions show different levels of fluorescence.
As in our previous studies, we present the red-to-blue (R/B)
intensity ratio rather than the red intensity alone, because taking
the ratio of the emitted red signal to a portion of the blue
excitation light helps eliminate variations due to day-to-day
fluctuations of the excitation source strength and geometrical
factors such as probe-to-tissue distance (Zheng et al, 2002). Thus,
the R/B ratio can be thought of as the red fluorescence normalised
to the blue excitation light. This ratio was observed to increase
progressively from normal to hyperplastic to SCC oral tissue, and
is to be expected, as lesions tend to retain drugs for a longer period
of time compared with normal tissue. At 2 hours after topical
application, most normal tissues will have cleared hypericin,
whereas lesions still show fluorescence. SCC tissue is likely to be
Figure 2 White light (A–C) and hypericin fluorescence (D–F) endoscopic images of normal (A, D), hyperplastic (B, E) and SCC (C, F) tongues.
The fluorescence images show a progressive increase in the red-to-blue intensity ratios from normal (R/B ratio¼0.3) to hyperplastic (R/B ratio¼1.0) to
SCC (R/B ratio¼2.0) tissue.
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spartially ulcerated and heavily inflamed. Highly vascular tissue is
likely to be close to the tissue surface, resulting in brighter
fluorescence compared with normal tissue. As shown in our
results, the R/B ratio is a good image parameter for distinguishing
between normal, hyperplastic and SCC tissue.
As hypericin fluoresces in the orange–red region (emission
peak about 590nm), the green fluorescence emitted is most likely
because of autofluorescence of the tissue. The green-to-blue (G/B)
intensity ratio, which can be thought of as autofluorescence
normalised to the blue excitation light, showed no particular trend
between normal, hyperplastic and SCC tissue (results not shown
here). Thus, the G/B ratio may not be a good image parameter for
distinguishing tissue types. On the other hand, the red-to-green
(R/G) intensity ratio, which can be thought of as a ratio of tissue
fluorescence to autofluorescence, could distinguish between
normal and hyperplastic tissue and between normal and SCC
tissue reasonably well in our study.
Among the patient pool, several special cases were excluded
from the ROC analysis and will be discussed here. The first case
is that of a patient who had undergone glossectomy and was
diagnosed as having hyperplasia of the floor of the mouth. Images
taken from the lesion showed low fluorescence and were dark,
whereas images taken from a normal part of the oral cavity in the
same patient were within the normal range. We theorise that in
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Figure 3 Bar charts showing the mean values of the red-to-blue intensity ratios (A), red-to-green intensity ratios (B), image hue (C) and image intensity
(D) in normal (n¼28), hyperplastic (n¼10) and SCC (n¼12) oral cavity tissue. Error bars are the s.e.m. Data were analysed using one-way ANOVA with
Bonferroni’s multiple comparison tests. Asterisks over the respective data pair indicate significant P-values (*Po0.05; **Po0.01; ***Po0.001).
Table 1 Performance indicators of image parameters, the mean red to blue (R/B) and red to green (R/G) intensity ratios, and the mean image hue and
intensity values, used to discriminate between normal (n¼28) and hyperplastic (n¼10) oral tissue
Image parameter Area under ROC curve (±s.e.) P-value Cutoff value Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Mean R/B 0.9964 (±0.006) o0.0001 40.422 100 96 91 100
Mean R/G 0.9071 (±0.05) 0.0002 42.435 100 75 59 100
Mean hue 1.0 (±0.0) o0.0001 4183.5 100 100 100 100
Mean intensity 0.8286 (±0.07) 0.002 441.56 100 64 50 100
Table 2 Performance indicators of image parameters, the mean red to blue (R/B) and red to green (R/G) intensity ratios, and the mean image hue and
intensity values, used to discriminate between normal (n¼28) and SCC (n¼12) oral tissue
Image parameter Area under ROC curve (±s.e.) P-value Cutoff value Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Mean R/B 1.0 (±0.0) o0.0001 40.740 100 100 100 100
Mean R/G 0.9464 (±0.03) 0.0002 42.509 100 75 63 100
Mean hue 1.0 (±0.0) o0.0001 4198.0 100 100 100 100
Mean intensity 0.9554 (±0.03) o0.0001 445.31 100 71 60 100
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spost-surgery tissue, the epithelium and vasculature may not have
recovered, resulting in low fluorescence, and the tissue may also
have low reflectivity, resulting in dark images.
A patient who had hyperplasia of the tongue with a
histologically confirmed presence of Candida was also excluded
from the ROC analysis. Candida is known to take up fluorescent
dyes, possibly resulting in a false positive (al-Bagieh, 1991). The
fluorescence images captured had R/B ratios that were higher than
the mean R/B value of hyperplastic lesions in our study.
Another case of interest was that of a patient with cellular
pleomorphic adenoma of the palate. As adenomas are glandular in
nature, they may accumulate a higher level of photosensitiser, thus
giving a higher level of fluorescence than usual. The fluorescence
images analysed yielded R/B ratios that were closer to those of SCC
than of benign hyperplastic lesions.
Finally, it is worthwhile to discuss where dysplasia fits in our
current set of results. As there were only four cases of dysplasia in
our patient pool, and this number is too small to form a category,
they were excluded from the ROC analysis. From the limited
number of images analysed, it seems that the red fluorescence level
in dysplasia lies somewhere in the upper half of the range of
hyperplasia fluorescence. It could thus be challenging to use
fluorescence imaging to distinguish dysplasia from hyperplasia
and SCC, but more data need to be collected to confirm this.
Although these special cases indicate the possible limitations of
fluorescence imaging in the diagnosis and staging of oral lesions,
the technique remains promising. Currently, image analysis takes
place offline and a digital diagnosis is determined only after
patient visit. Further development of a real-time image acquisition
and analysis system interfaced to the fluorescence endoscope will
allow acquired images to be analysed on the spot within automatic
or user-selected regions of interest to extract image parameters.
These image parameters can then be compared to pre-defined
threshold levels to determine whether the tissue is normal,
hyperplastic or malignant. This will enable same-day diagnosis
and cancer staging to be achieved in a clinical setting and provide a
visual aid for demarcation of tumour margins, thus enhancing the
clinical usefulness of fluorescence imaging.
In conclusion, hypericin fluorescence imaging is promising as a
complementary technique to white light endoscopy of human oral
cancers by facilitating guided biopsies in the clinic. This may
reduce the number of biopsies taken, enable delineation of tumour
margins during surgical procedures and provide a means for same-
day diagnosis in the clinic.
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